{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:13:51Z","timestamp":1760955231343,"version":"3.37.3"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1990,12,1]],"date-time":"1990-12-01T00:00:00Z","timestamp":660009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The effect of administration of cyclosporin A (CyA) or the novel macrolide FK506 was investigated in AO rats given DA blood transfusions. CyA (10 mg\/kg, orally) or FK506 (1 mg\/kg, intramuscularly) administered for 14 days from the time of transfusion effectively inhibited primary anti-MHC class I alloantibody production. This profound inhibitory effect persisted throughout the 2-month investigation period, with little increase in \u2018secondary\u2019 alloantibody production following a challenge injection 28 days after drug withdrawal. Flow cytometrie analysis revealed no significant differences in the absolute numbers of W3\/25+ (CD4+), OX-8+ (CD8+) or OX-12+ (B lymphocytes), in either the spleen or peripheral blood of transfused compared with normal, untreated animals. However, a small but significant increase in the numbers of splenocytes expressing the activation marker OX-40 (activated CD4+ cells) was observed in transfused animals. Either CyA or FK506 significantly reduced the number of cells expressing OX-39 (interleukin-2 receptors) and OX-40. Treatment of transfused animals with CyA, but not FK506 for 14 days resulted in minor, transient reduction in peripheral blood OX-19+ and W3\/25+ cells, while \u2018sparing\u2019 the OX-8+ cells; these changes were not observed in spleens. In contrast, the absolute spleen cell numbers of OX-19+, W3\/25+ and OX-8+ cells were significantly reduced in transfused animals given 14 days of FK506 treatment, while the corresponding blood cells were unaffected. Induction of splenic lymphoproliferative responses by the T cell mitogen concanavalin A remained normal in animals receiving transfusion alone or with CyA. In contrast, profound inhibition of mitogenic responses was observed in FK506-treated animals and this inhibitory effect declined gradually following drug withdrawal. No non-specific suppressor cell activity was detected in the spleens of rats given transfusion alone or in CyA or FK506-treated transfused animals.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1990.tb05472.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T09:48:30Z","timestamp":1280224110000},"page":"462-468","source":"Crossref","is-referenced-by-count":5,"title":["Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion"],"prefix":"10.1093","volume":"82","author":[{"given":"J","family":"WOO","sequence":"first","affiliation":[{"name":"Immunopathology Laboratory, Department of Pathology, University of Aberdeen, Aberdeen, Scotland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D J","family":"PROPPER","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, Scotland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"MACLEOD","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, Scotland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A W","family":"THOMSON","sequence":"additional","affiliation":[{"name":"Immunopathology Laboratory, Department of Pathology, University of Aberdeen, Aberdeen, Scotland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011713211834600_b1","first-page":"273","article-title":"Report of the First International Workshop on allogeneic system in the rat","volume":"10","author":"Butcher","year":"1978","journal-title":"Transplant. Proc."},{"issue":"Suppl. 6","key":"2022011713211834600_b2","first-page":"62","article-title":"Kidney transplantation in the dog receiving FK-506","volume":"19","author":"Collier","year":"1987","journal-title":"Transplant. Proc."},{"key":"2022011713211834600_b3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00007890-198801000-00042","article-title":"Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK-506","volume":"45","author":"Inamura","year":"1988","journal-title":"Transplantation"},{"key":"2022011713211834600_b4","first-page":"153","article-title":"Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506","volume":"65","author":"Kay","year":"1989","journal-title":"Immunology"},{"key":"2022011713211834600_b5","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","article-title":"FK-506, a novel immuno-suppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro","volume":"40","author":"Kino","year":"1987","journal-title":"J. Antibiotics"},{"key":"2022011713211834600_b6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00007890-198105010-00019","article-title":"Cyclosporin A can abrogate the sensitizing effect of blood transfusion in rats without interfering with its beneficial influence","volume":"31","author":"Maroukt","year":"1981","journal-title":"Transplantation."},{"key":"2022011713211834600_b7","first-page":"359","article-title":"The influence of tumour carriage on the production of lymphokines affecting macrophage behaviour","volume":"57","author":"McIntosh","year":"1986","journal-title":"Immunology"},{"key":"2022011713211834600_b8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00007890-198712000-00001","article-title":"Studies of the effects of FK-506 on renal allografting in the beagle dog","volume":"44","author":"Ochiai","year":"1987","journal-title":"Transplantation."},{"key":"2022011713211834600_b9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/00007890-198712000-00002","article-title":"Studies on the induction and maintenance of long-term graft acceptance by treatment with FK-506 in heterotopic cardiac allotransplantation in rats","volume":"44","author":"Ochiai","year":"1987","journal-title":"Transplantation."},{"key":"2022011713211834600_b10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00007890-198904000-00023","article-title":"Mediation of the induction of immunologic unresponsiveness following antigen pretreatmenl by a CD4 (W3\/25+) T cell appearing transiently in the splenic compartment and subsequently in the TDL","volume":"47","author":"Quigley","year":"1989","journal-title":"Transplantation"},{"key":"2022011713211834600_b11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00007890-198904000-00022","article-title":"Mediation of antigen-induced suppression of renal allograft rejection by a CD4 (W3\/25+) T cell","volume":"47","author":"Quigley","year":"1989","journal-title":"Transplantation."},{"key":"2022011713211834600_b12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000658-198010000-00012","article-title":"Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach","volume":"192","author":"Salvatierka","year":"1980","journal-title":"Ann. Surg."},{"issue":"Suppl. 1","key":"2022011713211834600_b13","first-page":"35","article-title":"The side effects of FK-506 in humans","volume":"22","author":"Shapiro","year":"1990","journal-title":"Transplant. Proc."},{"key":"2022011713211834600_b14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(89)91014-3","article-title":"FK-506 for liver, kidney and pancreas transplantation","volume":"ii","author":"Starzl","year":"1989","journal-title":"Lancet"},{"key":"2022011713211834600_b15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0167-5699(89)90057-1","article-title":"FK-506. How much potential","volume":"10","author":"Thomson","year":"1989","journal-title":"Immunol. Today."},{"issue":"Suppl. 1","key":"2022011713211834600_b16","first-page":"96","article-title":"Interspecies comparison of the immunosuppressive efficacy and safety of FK-506","volume":"22","author":"Thomson","year":"1990","journal-title":"Transplant. Proc."},{"key":"2022011713211834600_b17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.143.2.718","article-title":"The immunosuppressant FK-506 selectively inhibits expression of early T cell activation genes","volume":"143","author":"Tocci","year":"1989","journal-title":"J. Immunol."},{"issue":"Suppl. 1","key":"2022011713211834600_b18","first-page":"13","article-title":"Early trials with FK-506 as primary treatment in liver transplantation","volume":"22","author":"Todo","year":"1990","journal-title":"Transplant. Proc."},{"key":"2022011713211834600_b19","first-page":"239","article-title":"Immunosuppression of canine, monkey and baboon allografts by FK-506: with special reference to synergism with other drugs and to tolerance induction","volume":"104","author":"Todo","year":"1988","journal-title":"Surgery"},{"key":"2022011713211834600_b20","first-page":"149","article-title":"Augmentation of delayed-type hypersensitivity to high dose sheep erythrocytes by cyclosporin A in the mouse: influence of drug dosage and route of administration and analysis of spleen cells populations","volume":"71","author":"Webster","year":"1988","journal-title":"Clin. exp. Immunol."},{"key":"2022011713211834600_b21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-3083.1990.tb02772.x","article-title":"The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis","volume":"31","author":"Woo","year":"1990","journal-title":"Scand. J. Immunol."},{"key":"2022011713211834600_b22","first-page":"153","article-title":"Spleen lymphocyte populations and expression of activation markers in rats treated with the potent new immunosuppressive agent FK-506","volume":"65","author":"Woo","year":"1988","journal-title":"Immunology"},{"key":"2022011713211834600_b23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2249.1990.tb05136.x","article-title":"Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal","volume":"79","author":"Woo","year":"1990","journal-title":"Clin. exp. Immunol."},{"key":"2022011713211834600_b24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00007890-198902000-00035","article-title":"Effect of a new immunosuppressive agent, FK-506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and \u03b3-IFN, but not B cell-stimulating factor 2","volume":"47","author":"Yoshimura","year":"1989","journal-title":"Transplantation."}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1990.tb05472.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/82\/3\/462\/42217352\/j.1365-2249.1990.tb05472.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/82\/3\/462\/42217352\/j.1365-2249.1990.tb05472.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T11:52:35Z","timestamp":1740311555000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/82\/3\/462\/6488755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1990.tb05472.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"type":"electronic","value":"1365-2249"},{"type":"print","value":"0009-9104"}],"subject":[],"published-other":{"date-parts":[[1990,12]]},"published":{"date-parts":[[1990,12]]}}}